Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): A Prospective Study

被引：0
|
作者：
Ma, Xinlei [1 ]
Yang, Fan [1 ]
Lin, Jin [1 ]
Chen, Weiqian [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Div Rheumatol, Sch Med, Hangzhou, Peoples R China
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1107
引用
收藏
页码：2198 / 2200
页数：3
相关论文
共 50 条
  • [41] Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR Cohort Study
    Muller, Sara
    Hider, Samantha L.
    Helliwell, Toby
    Lawton, Sarah
    Barraclough, Kevin
    Dasgupta, Bhaskar
    Zwierska, Irena
    Mallen, Christian D.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [42] HIGH LEVEL OF ADHERENCE TO OSTEOPOROSIS PROPHYLAXIS MEDICATIONS IN STEROID-TREATED POLYMYALGIA RHEUMATICA (PMR)/GIANT CELL ARTERITIS (GCA) PATIENTS: A PROSPECTIVE COHORT STUDY
    Emamifar, A.
    Ellingsen, T.
    Hermann, A. P.
    Hess, S.
    Hansen, I. M. Jensen
    Thye-Ronn, P.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S93 - S93
  • [43] Efficacy and Safety of Tocilizumab in Polymyalgia Rheumatica: A Systematic Review and Meta-Analysis
    Sharma, Meha
    Das, Siddharth Kumar
    Mohindra, Ritin
    Dutta, Deep
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2025, 28 (02)
  • [44] POLYMYALGIA RHEUMATICA - CLINICAL-STUDY OF 17 PATIENTS
    ANDRADA, SS
    PEREZ, JM
    SAGREDO, JLP
    MARTINEZ, JO
    VALVERDE, VR
    MEDICINA CLINICA, 1981, 77 (09): : 361 - 366
  • [45] CURRENT EVIDENCE ON PROGNOSTIC FACTORS IN PATIENTS WITH POLYMYALGIA RHEUMATICA (PMR): A SYSTEMATIC LITERATURE REVIEW INFORMING THE ACR/EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF PMR
    Dejaco, C.
    Singh, Y.
    Perel, P.
    Hutchings, A.
    Matteson, E. L.
    Dasgupta, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 553 - 553
  • [46] REAL-WORLD EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH POLYMYALGIA RHEUMATICA
    Imai, Y.
    Takanashi, S.
    Kaneko., Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [47] THE EFFICACY AND SAFETY OF TOCILIZUMAB THERAPY IN PATIENTS WITH POLYMYALGIA RHEUMATICA WHO WERE RESISTANT OR INTOLERANT TO GLUCOCORTICOIDS AND ADDITIONAL METHOTREXATE
    Ueno, A.
    Yamamura, Y.
    Fujita, K.
    Shibutou, N.
    Yamamura, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 605 - 605
  • [48] Validation of the polymyalgia rheumatica-activity score: A prospective cohort study
    Moreel, Lien
    Doumen, Michael
    Betrains, Albrecht
    De Langhe, Ellen
    Blockmans, Daniel
    Vanderschueren, Steven
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 72
  • [49] CARDIOVASCULAR RISK FACTORS ARE ASSOCIATED WITH THE ONSET OF POLYMYALGIA RHEUMATICA (PMR) AND GIANT CELL ARTERITIS (GCA) IN A PROSPECTIVE COHORT: EPIC-NORFOLK STUDY
    Yates, Max
    Luben, Robert
    Hayat, Shabina
    Mackie, Sarah L.
    Watts, Richard A.
    Khaw, Kay-Tee
    MacGregor, Alex J.
    RHEUMATOLOGY, 2018, 57
  • [50] EFFICACY AND SAFETY OF TOFACITINIB VERSUS LEFLUNOMIDE TREATMENT IN TAKAYASU ARTERITIS: A PROSPECTIVE STUDY
    Wang, J.
    Dai, X.
    Ma, L.
    Wu, S.
    Jin, X.
    Ji, Z.
    Chen, H.
    Ma, L.
    Ding, Z.
    Jiang, L.
    Kong, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 686 - 687
12345